Discovering compounds mimicking calorie restriction using mammalian gene expression profiles
Abstract
Obesity is a risk factor for cardiovascular diseases, diabetes and cancer. In theory the obesity problem could be solve by the adherence to a calorie restricted diet, but that is not generally achieved in practice. An alternative is a pharmacological approach, using compounds that trigger the same metabolic changes associated with calorie restriction. Here I expand in the pharmacological direction by identifying compounds that induce liver gene signature profiles that mimic those induced by calorie restriction. Using gene expression profiles from mice and rat I identify corticosteroids, PPAR agonists and some antibacterial/antifungal as candidate compounds mimicking the response to calorie restriction in the liver gene signatures. Liver gene signature analysis can be used to identify compounds that mimic calorie restriction.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 2
- FWCI
- 0.08
- Field percentile
- 35th percentile
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- An LRH-1 agonist reverses hepatic metabolic dysfunction in obesity
Suzanne G Mays, André R Cuevas, … John W Calvert·bioRxiv·Nov 3, 2026
- Mass Recovery following Caloric Restriction Reverses Lipolysis and Proteolysis, but not Gluconeogenesis, in Insulin Resistant OLETF Rats
M. A. Cornejo, J. Dhillon, … R. M. Ortiz·bioRxiv·May 17, 2021
- Liver-specific loss of the transcriptional coregulator ARGLU1 protects against diet-induced obesity in mice through decreased lipid absorption
Sarah B. Cash, Michael Fadi Saikali, … Carolyn L. Cummins·bioRxiv·Feb 5, 2026
- A dietary intervention following incretin analog treatment restores adipose tissue functions in diet-induced obese mice
Joke Seuntjens, Jente De Gols, … Mitsugu Shimobayashi·American Journal of Physiology-Endocrinology and MetabolismPeer-reviewed·May 28, 2025
- Liver Fibroblast Growth Factor 21 (FGF21) is Required for the Full Anorectic Effect of the Glucagon-Like Peptide-1 Receptor Agonist Liraglutide in Male Mice fed High Carbohydrate Diets
T. D. V. Le, P. Fathi, … J. E. Ayala·bioRxiv·Jan 3, 2023
- Urinary Signatures Predict Calorie Restriction-Mediated Weight Loss in Obese Diversity Outbred Mice
Evan M. Paules, Isis Trujillo‐Gonzalez, … Stephen David Hursting·bioRxiv·Jul 18, 2025